I worked at Oxford BioMedica
Great people and facilities. Exciting product pipeline from many angles. Takes time out to celebrate and reward staff. Opportunity to work on genuinely important and interesting topics of your into bioscience and biomanufacturing.
Quite a lot of bureaucracy. No real onboarding structure other than basic health and safety. Management not transparent. Slow pace of work. I didn't personally connect with the culture there but others seemed to enjoy the atmosphere.
Advice to Management
If you want to recruit and retain talent invest in people early, give them exciting work and provide some useful structure. Otherwise you're self selecting hires who will put up with average performance and slow progress.
Let us know if we're missing any workplace or industry recognition –
Oxford BioMedica has no reservations about launching attacks on disease. The biotechnology company uses gene therapy and immunotherapy to develop treatments for cancer, as well as neurodegenerative and ocular diseases. Its four ocular gene therapies are partnered with Sanofi; the company works with Pfizer on another targeted antibody therapy. The company has three lead products: TroVax, ProSavin, and RetinoStat (being developed with Sanofi). TroVax is in late-stage clinical trials for the treatment of prostate cancer. ProSavin is being tested to treat Parkinson's ...